Crossroads of Philadelphia, PA (West Philly)Suboxone Clinic
Our suboxone clinic is dedicated to providing comprehensive support and effective treatment options for individuals seeking opioid addiction treatment. Our outpatient addiction treatment center combines medical expertise with compassionate care to guide you toward a successful recovery.
323 South 60th Street
Philadelphia, PA 19143
Call Center Open 24/7/365
Same-day and Virtual Appointments Available
- Center Offerings Care Coordination, Hepatitis C Treatment
In-Network Insurances
- Commercial
- Aetna
- Capital BCBS
- Cigna
- Evernorth
- Geisinger
- Highmark BCBS
- Humana
- Independence BCBS
- Keystone Health Plan East
- PA Health & Wellness
- United Healthcare
- UPMC
- Exchange Plan
- Aetna Better Health
- Amerihealth
- Geisinger
- Highmark Wholecare
- Jefferson Health (Health Partners)
- Keystone
- PA Health & Wellness
- United Healthcare
- UPMC
- Aetna
- Amerihealth
- Capital BCBS
- Evernorth
- Geisinger
- Highmark BCBS
- Highmark Wholecare
- Humana
- Jefferson Health (Health Partners)
- Keystone
- PA Health & Wellness
- United Healthcare
- UPMC
About Our Opioid Addiction Treatment Services in West Philadelphia
At Crossroads of West Philadelphia, our goal is to create a supportive environment that fosters healing and growth. Treatment for opioid use disorder requires a tailored approach, which is why our addiction treatment center in West Philadelphia is staffed by professionals who are committed to your well-being.
Medications We Offer in West Philadelphia for Opioid Use Disorder
Buprenorphine (Rx): The buprenorphine program at Crossroads offers an alternative treatment option for opioid addiction. Buprenorphine helps manage withdrawal symptoms and reduce cravings. Our experienced medical staff will work with you to develop a personalized treatment plan that includes regular monitoring.
Buprenorphine (SUBLOCADE®): Sublocade is an extended-release formulation of buprenorphine, a partial opioid agonist. It helps reduce cravings and withdrawal symptoms while providing a ceiling effect that lowers the risk of overdose. It is administered as a subcutaneous injection once a month.
Buprenorphine (BRIXADI®): Similar to Sublocade, this formulation of buprenorphine is designed for long-acting use to support recovery from opioid addiction. It is typically administered as a subcutaneous injection, with dosing frequency varying based on the specific formulation (weekly, biweekly, and monthly).
Naltrexone (VIVITROL®): Vivitrol is an extended-release injectable form of naltrexone. It is used to prevent relapse in individuals who have already detoxified from opioids. Naltrexone is an opioid antagonist, meaning it blocks the effects of opioids and reduces cravings. It is given as an intramuscular injection once a month.
About Our Hepatitis C Treatment Services in West Philadelphia
We are dedicated to addressing your comprehensive health needs, including the treatment of Hepatitis C. By integrating Hepatitis C care into our substance use disorder services, we strive to improve health outcomes and enhance the quality of life for those we serve. Treating Hepatitis C is a vital component of long-term recovery, helping to reduce liver-related complications and promote overall wellness.
Why Choose Crossroads?
At our addiction treatment center in West Philadelphia, we are dedicated to improving the lives of our patients and their families. We believe in treating each person with respect and dignity, offering a welcoming environment where all can feel safe and supported.
Our experienced team, proven treatment methodologies, and ongoing support systems ensure that every individual has the best chance to succeed in overcoming addiction. Join us and start your journey to a healthier, drug-free life today. Experience dedicated care at our addiction treatment center, offering tailored opioid recovery programs.
About Philadelphia
Philadelphia, rich in historical significance and cultural vibrancy, is also home to many individuals struggling with opioid addiction. The city’s diverse population includes a wide range of people affected by this crisis, underscoring the need for effective treatment solutions that are accessible to all.